4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-030485
Chief Operating Officer sold 29,491 shares at an average $26.59 ($784,248)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HIGH SUSANNA GATTI Chief Operating Officer | 2024-03-08 | Sale 10b5-1 | −26,908 | $26.66 | $717,367 | 159,383 | D |
| HIGH SUSANNA GATTI Chief Operating Officer | 2024-03-08 | Sale 10b5-1 | −291 | $27.41 | $7,976 | 159,092 | D |
| HIGH SUSANNA GATTI Chief Operating Officer | 2024-03-11 | Sale 10b5-1 | −2,292 | $25.70 | $58,904 | 156,800 | D |
| Open-market sales · 29,491 sh · avg $26.59 · $784,248 | |||||||
Loading xslF345X05/ownership.xml…